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Summary We have constructed cDNA libraries from the poly(A)+ RNA of normal colonic mucosa and a
liver metastasis from a colonic adenocarcinoma. Differential screening of these libraries using 32P-labelled
cDNAs transcribed from poly(A)+ RNAs isolated from specimens of four normal colonic mucosae, five
adenocarcinomas, and three liver metastases by Grunstein-Hogness and dot-blot hybridisation has identified a
number of recombinant cDNA clones homologous to mRNAs that appear to differ significantly in abundance
between normal and neoplastic colon and metastases.
These cDNA clones, and others identified in the libraries, may be of considerable importance both as
diagnostic tools and in defining the phenotypic changes associated with tumour progression and metastasis.
One of the major causes of failure in the treatment of
colorectal cancer is the occurrence of metastatic disease,
involving primarily the liver and lungs, and occasionally
bone. By the time of first presentation, between 15-25% of
patients have metastases to the liver (Welch & Donaldson,
1978), while it has been more recently shown that about
30% of patients undergoing apparently curative resection for
colorectal cancer possess occult hepatic metastases (Finlay &
McArdle, 1982). Furthermore, in a study of occult metastatic
disease using computerised tomography (Finlay & McArdle,
1982) it was shown that the presence or absence of
metastatic disease at the time of clinical presentation is the
most critical prognostic factor, accounting almost entirely for
the observed pattern of mortality. The identification of those
patients with occult metastatic disease is clearly of
considerable importance in planning therapy and, in
addition, would avoid the unnecessary further treatment of
that group of patients surgically cured of their disease
(Taylor et al., 1985).
The aggressiveness of colorectal tumours is currently
assessed using the Dukes classification (Dukes, 1932).
However, this, together with other prognostic indicators such
as tumour morphology and serum levels of carcinoembryonic
antigen (CEA), do not reliably correlate with clinical
outcome (Finlay & McArdle, 1982; Lewi et al., 1984).
Measurement of DNA distribution patterns in tumour cell
nuclei suggest that tumour ploidy may be of prognostic
value, non-diploid tumours tending to be more aggressive
(Wolley et al., 1982). The few clinically applicable markers
that exist for colorectal cancer are of little specificity either
for the diagnosis or for monitoring the course of the disease
(Schwartz, 1980), although it has been suggested that serum
levels of CEA (Tate, 1982) and alkaline phosphatase (Aabo
et al., 1986) may be used as indicators of recurrence and of
secondary disease. However, these markers do not allow a
distinction between recurrent local and metastatic disease
(Hine & Dykes, 1984).
Although many features of tumour cells have been studied
in relation to metastasis (reviewed in Weiss, 1985), as yet no
single variable has been consistently identified as being
associated with the metastatic phenotype and there is no
clinically reliable means of predicting the metastatic potential
of a tumour. Metastasis is considered to be a multistep
process (reviewed in Hart & Fidler, 1980; Nicolson, 1982;
Schirrmacher, 1985) involving many phenotypic charac-
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teristics expressed as a consequence of the activity of many
gene loci, and thus would be expected to be reflected in
changes in the relative abundances of a number of specific
mRNAs.
Variations in the abundances of individual mRNAs can be
detected and measured by the application of molecular
cloning techniques which allow the identification of
previously uncharacterised genes that are associated with a
particular cell phenotype. Recombinant complementary
DNA (cDNA) libraries have been used, for example, to
identify mRNA sequences associated with normal
development (Sim et al., 1979), transformation (Augenlicht
& Kobrin, 1982), dysplastic changes in human colonic
mucosa (Bartsch et al., 1986) and to isolate cDNA probes
that can be used to classify leukaemias (Weidemann et al.,
1983; Warnock et al., 1985; Mars et al., 1985).
In this paper we describe the application of the same
approach to identify some of the genes that are differentially
expressed during tumour progression and metastasis in
colorectal cancer, which may be expected to be of
importance in defining the development of metastases, and
of clinical usefulness as prognostic markers of metastases in
colorectal cancer. A preliminary account of this work has
been published (Elvin et al., 1986).
Materials and methods
Tissues
Specimens of histologically confirmed adenomatous polyps,
colorectal tumours, liver metastases from colorectal tumours
and specimens of histologically normal colonic mucosae
obtained from tissue adjacent to the resection margins of
surgically removed colorectal tumours, were obtained from
patients undergoing surgery at Glasgow Royal Infirmary.
Patients receiving chemotherapy were excluded from this
study. All tissues were immediately frozen in liquid nitrogen
and stored at -70°C until required.
Isolation oftotal RNA
Total RNA was isolated from the frozen tissue specimens by
a modification of the method of Chirgwin et al. (1979),
which yields undegraded total RNA suitable for the isolation
of poly(A)+ RNA, overcoming the high level of activity
associated with endogenous RNAases in these tissues. A
sample (-0.5-1 g) of the tissue specimen was ground to a
fine powder under liquid nitrogen in a pre-cooled porcelain
mortar and pestle. The ground tissue was lysed by transfer
to 20ml of guanidinium thiocyanate solution (5M
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guanidinium thiocyanate, 5% mercaptoethanol, 50mM tris-
HCI, 50mM EDTA, pH 7.0). DNA was fragmented by
sonication, 1/10 vol 20% sarcosine added and the solution
warmed to 55°C in a water bath for two minutes. Gross
tissue debris was removed by centrifugation at 1000rpm for
10min in a MSE 4L centrifuge. The solution was layered
over a cushion of CsCl (5.7M CsCl, 50mM EDTA, pH7.0;
refractive index 1.3995) and centrifuged at 22,000rpm
(60,000ga), at 17°C for 48 h in an IEC SB-110 rotor.
The pellets were resuspended in sterile water and
precipitated by adding 1/10 vol 3M sodium acetate and 3 vol
absolute ethanol. The solution was kept at -20°C overnight,
and the precipitated material recovered by centrifugation at
10,000 rpm (8700ga,) at 4°C for 20min in a Sorvall HB4
rotor. The pellets were washed in 70% and 95% ethanol and
finally resuspended in strilic water at a concentration of
- I mgml-1.
Poly(A)+ RNAs werc isolkted from total RNAs by the
method of Aviv and Leder (1972) using oligo(dT)-cellulose
(BRL), recovered by precipitation and washed as described
above, and finally resuspended in sterile water at a
concentration of 250pgml- 1 and stored at -20°C.
cDNA library construction
Double-stranded cDNAs were synthesised from poly(A)+
RNAs by the method of Wickens et al. (1978). Oligo(dT)-
primed poly(A)+ RNA was reverse transcribed by AMV
reverse transcriptase (Bio-Rad Laboratories) to generate a
first strand with a hairpin loop which was used to prime
second strand synthesis by E. coli DNA polymerase I
(Boehringer). The hairpin loop was removed by digestion
with SI nuclease and the resultant cDNA was blunt-end
ligated into the Smal site of plasmid pUC8. The
recombinant plasmids were used to transform E. coli JM83
and individual recombinant clones were grown on L-agar
9cm plates. Individual colonies were picked, inoculated, and
grown in 96-well microtitre plates (Flow Laboratories),
duplicated and stored at -20°C. Simultaneously, using a
transfer plate (Dynatech), two nylon filter (Biodyne A,
PALL) replicas of each plate were copied, and the bacterial
DNA lysed and baked onto the filters for screening.
cDNA probe preparation and colony hybridisation
All of the probes used to screen the libraries were single-
stranded cDNAs synthesised from poly(A)+ RNAs using
AMV reverse transcriptase (Bio-Rad Laboratories) and
32P-dCTP (cX-32P-dCTP, - 400Ci mmol -1, Amersham
International plc) as label. Colony hybridisation (Grunstein
& Hogness, 1975) to the nylon filter replicas of the cDNA
libraries was carried out as described by the manufacturer
(PALL) at 65°C for at least 12h using a probe concentration
of 0.5-1 x 106 cpmml-1. Excess probe was removed by three
half-hour washes in a washing buffer (5mM NaH2PO4, 1 mM
EDTA, 0.2% SDS) at 65°C. Colony hybridisation was
visualised by autoradiography at -70°C using Kodak X-
Omat film and Dupont Lightning Plus intensifying screens.
Plasmid DNA isolation and dot-blot hybridisation
Small-scale bacterial cultures (2ml overnight cultures) were
used for the isolation of plasmid DNA by the method of
Birnboim and Doly (1979). The DNAs were dot blotted onto
Biodyne A nylon membrane illcr-s, denatured and baked
as described by the manufacturers (PALL) prior to
hybridisation under conditions as described for colony
hybridisation. For further study plasmids were isolated from
500ml overnight cultures, using the alkaline lysis method of
Birnboim and Doly (1979). The plasmids were purified by
CsCl and sucrose gradient centrifugation. Recombinant
plasmids were finally resuspended in TE buffer (10mM tris-
HCI, 1 mM EDTA, pH 8.0) at a concentration of 250 pgml -
and stored at 4°C.
Northern blot analysis and dot-blot analysis oftotal RNA
Total and poly(A)+ RNAs in a buffer solution containing
50% formamide and 2.2M formaldehyde were heated to
65°C for 10min, chilled on ice, and electrophoretically
fractionated on 1% agarose-formaldehyde gels prior to
Northern blotting onto nitrocellulose as described by
Thomas (1980).
Serial doubling dilutions of total RNAs in sterile water
were heated to 65°C for 15min and chilled on ice before dot
blotting onto nitrocellulose that had been previously wetted
in 20X SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0) and air
dried. Each serial dilution was dot blotted in duplicate, and
replica filters of the same samples were prepared. The RNAs
were immobilised onto the nitrocellulose by baking for 2h at
800C.
Southern blot analysis
Restriction enzyme digested normal human white blood cell
DNA, 18pg per lane, was electrophoretically fractionated
overnight on 1% agarose gels, and then transferred to
nitrocellulose using a modification of the method of
Southern (1975).
Hybridisation conditions
Recombinant plasmids were radioactively labelled by nick-
translation using 32P-dCTP (a-32P-dCTP, - 400 Cimmol-1,
Amersham International plc). Nitrocellulose filters were pre-
hybridised in a buffer containing 50% formamide, 0.1%
SDS, 5X Denhardt's (0.1% ficol 400K MW, 0.1% polyvinyl
pyrolidine 360K MW, 0.1% bovine serum albumin), SX
SSC, 50mM sodium phosphate, 500pgml-1 salmon sperm
DNA, 10pgml-l each of poly(A) and poly(C), 1% glycine,
pH 7.0, for at least 12h at 42°C. Hybridisations were carried
out in a buffer containing 50% formamide, 10% dextran
sulphate, 0.1% SDS, SX SSC, IX Denhardt's, 20mM sodium
phosphate, 100 pgml-1 each of poly(A) and poly(C), pH7.0,
for at least 12 h at 42°C with a probe concentration of
0.5-1 x 106 cpmml-1. Following hybridisation filters were
washed at 65°C in 2X SSC, 0.1% SDS, then 0.5X SSC,
0.1% SDS and finally 0.1X SSC, 0.1% SDS, and exposed to
Kodak X-Omat film with intensifying screens at - 70°C.
Results
Screening ofcDNA libraries
A cDNA library of - 5,000 clones representative of normal
colonic mucosa poly(A)+ RNAs was screened with probes
generated from poly(A)+ RNAs according to the scheme
outlined in Figure 1. Initially, in order to accommodate any
inter-patient variation in gene expression, the library was
screened with cDNA probes transcribed from RNAs from
four different normal mucosae. On this basis 912 recom-
binant clones representing poly(A)+ RNA sequences of high
and medium abundance classes were identified as being
common to the mucosae RNAs. Further screening of these
recombinants, firstly with cDNA probes derived from two
normal mucosae specimens, to establish a base-line relative
hybridisation pattern, and secondly with cDNA probes
derived from 5 different colonic tumours, identified 89
recombinants representing abundant sequences in normal
colonic mucosae which were of significantly altered
abundance in colorectal tumours on the basis of differences
in the intensities of the autoradiographic signals.
Since the results of Grunstein-Hogness colony screening
depend not only on the degree of specific hybridisation with
the probes used but also on a number of variables, such as
growth of a particular clone in the microtitre plate, the
reproducibility of transfer and growth of bacterial colonies
on the nylon filters, and recombinant plasmid copy number,
plasmid DNA was isolated as described from each of the 89
recombinants and dot blotted in duplicate onto each of four38 P. ELVIN et al.
Normal colonic mucosa
cDNA library
about 5000 clones
Colony hybridisation 1
probesa normal mucosae (4
912 clones
Colony hybridisation 2
probes: normal mucosae (2)
colorectal ca (5)
89 clones
Plasmid DNA dot-blot
hybridisation
probes: normal mucosae (3)
colorectal ca (3)
liver metastases (3)
Liver metastasis
cDNA library
about 3000 clones
probes: liver metastases (2)
colorectal ca (4)
288 clones
I
probes: normal mucosae (3)
colorectal ca (3)
liver metastases (3)
normal liver (1)
82 clones
probes: normal mucosae (3)
colorectal ca (3)
liver metastases (3)
normal liver (1)
Figure 1 Screening protocol for cDNA libraries: identification
of recombinants associated with tumour stage. (a) All probes
were 32P-cCTP-labelled cDNAs revenue transcribed from
poly(A)+ RNAs. (b) Figures in brackets indicate the number of
different tissue specimens used to generate cDNA probes at each
stage of screening.
replica nylon filters. Hybridisation of plasmid DNA dot
blots with cDNA probes generated from normal colonic
mucosae, colonic tumours, and liver metastases of colonic
tumours was carried out sequentially such that no individual
filter was re-hybridised with an identical class of probe, each
filter was hybridised with each of the aforementioned classes
of probe, and three different tissue specimens from each
histological tissue type were used.
The colony hybridisation and plasmid DNA dot blot
assays identified a number of recombinant clones as being
representative of RNAs associated with different stages of
tumour progression. These clones are detailed in Table I.
From the normal colonic mucosa library, six clones were
identified as representing sequences of considerably reduced
abundance in, or absence from, secondary tumours
compared to primary tumours or normal tissue. In addition,
a group of seven clones also represented sequences of
reduced abundance in secondary tumours compared to
normal tissue and primary tumours, which were assigned to
a separate group on the basis of this semi-quantitative
screening. A further group of seven clones appeared to
represent sequences of increased abundance in primary
tumours compared to normal tissue or secondary tumours.
No clones apparently representing secondary tumour-specific
Table I Recombinant cDNA dot blot hybridisation to cDNA
probes from Aistologically graded tissues
Relative hybridisation to cDNA
probes representing
Origin of Number Primary Secondary
recombinant clones ofclonesb Mucosa tumour tumour
Normal colonic 6 + c +
mucosa 7 + + +/-
cDNA library 7 + + + +
Liver metastasis 8 + + + +
cDNA library 6 + + + +
a32P-labelled single-stranded cDNAs reverse transcribed from total
poly(A)+ RNA. bClones grouped on the basis of hybridisation of
plasmid DNA dot blots with the probes indicated; identical results
obtained with probes derived from three specimens of each tissue
type. CHybridisation signals: + +, very strong; +, strong; -, weak
or absent.
sequences were identified in the normal colonic mucosa
library.
In order to identify sequences specifically associated with
metastasis, a cDNA library of -3,000 clones representing
the more abundant poly(A)+ RNAs of a liver metastasis
from a colorectal tumour was also screened as outlined in
Figure 1. Sequences common to liver metastases, but of
altered abundance in primary tumours, were identified by
differential screening with cDNA probes derived from two
secondary and four primary colorectal tumours. Further
screening of these selected clones with cDNA probes derived
from liver metastases, primary tumours, normal colonic
mucosae and normal human liver identified 82 clones that
represented RNA sequences in metastases which were of
altered abundance in primary tumours, but were absent from
the total RNA isolated from normal human liver. Plasmid
DNA was isolated from these recombinant clones and
hybridised with three different cDNAs transcribed from
RNA from each histologically graded tissue type.
This screening protocol identified two groups of clones in
the liver metastasis library: a group of six clones representing
sequences of increased abundance in primary tumours
compared to normal colonic mucosa or secondary tumours,
and a group of eight clones representing sequences of
increased abundance in secondary tumours compared to
normal tissue or primary tumours (Table I).
On the basis of these semi-quantitative changes in
hybridisation signal intensity, four recombinant clones from
the normal colonic mucosa library and one recombinant
clone from the liver metastasis library were selected for
further characterisation by Northern blot and RNA dot-blot
analysis.
Characterisation ofselected recombinants:
Northern blot analysis
Following restriction enzyme digestion of recombinant
plasmids, the cDNA inserts in the recombinants pNM19,
pNM32, pNM41 and pNM61 from the normal colonic
mucosa library, and pLM59 from the liver metastasis library,
were shown to be of between 230-530bp by agarose gel
electrophoresis. Northern blotting of total RNA from a
specimen of normal colonic mucosa, followed by
hybridisation with nick-translated plasmids, identified these
recombinants as being homologous to RNAs of between 0.8
and 2.1 kb (Figure 2 and Table II). In addition, sequences
homologous to the recombinant clone pLM59, which
represented an RNA of increased abundance in metastases
relative to normal tissue, could be detected in total RNAs
from patients both with and without a clinical history of
disseminated disease (Figure 3). Southern blot analysis of
EcoRI and HindlIl digested normal human white blood cell
DNA (results not shown) indicated that each of these
recombinants represented unique RNAs.
RNA dot blot analysis
The relative abundances of RNA sequences homologous to
the five recombinants, that on the basis of prior semi-
quantitative screening, were closely associated with
metastases were determined in a series of tissue specimens
corresponding to different stages of colorectal tumour
Table II Characteristics of five selected cloned
sequences
Size ofcDNA Size ofhomologous
cDNA clone insert (bp) RNA (kb)
pNM19 530 1.2
pNM32 485 1.2
pNM41 420 1.9
pNM61 230 2.1
pLM59 400 0.8METASTASIS IN COLORECTAL CANCER 39
Normal colonic Colonic Liver
mucosae adrenocarcinomata metastases
19 32 KY1. k W-
41 6.1 59
Figure 2 Northern blot analyses of normal mucosa RNA. Total
RNA (10,jg per lane) from a sample of normal colonic mucosa
was electrophoretically fractionated on a 1% agarose-
formaldehyde gel and transferred to nitrocellulose. Individual
lanes were hybridised with labelled recombinant plasmid probes
pNM19, pNM32, pNM41, pNM61 and pLM59 as indicated (19,
32, 41, 61, 59, respectively).
28S -
23S -
18S5-
16S-
- 0.83 kb
1 2 3 4 5 6 7 8 9 10
Figure 3 Northern blot analyses of RNAs from mucosae,
primary colon tumours and liver metastases. Total RNA (10pg
per lane) was electrophoretically fractionated on a 1% agarose-
formaldehyde gel, transferred to nitrocellulose and hybridised
with 32P-labelled recombinant pLM59 DNA. RNAs were from:
lanes 1-4, normal colonic mucosae; lanes 5-7, primary colon
tumours; lanes 8 and 9, liver metastases; lane 10, normal human
liver. RNAs in lanes 1, 2 and 7 were prepared from tissue
samples obtained from patients with confirmed metastatic
disease, RNAs in lanes 3-6 were prepared from tissue samples
obtained from patients with no evidence of secondary disease at
the time of surgery.
progression (see for example Figure 4). Four of the
recombinants, clones pNMl9, pNM32, pNM41 and pNM61,
were found to represent RNAs reduced 5- to 10-fold in
abundance in metastases relative to primary tumours, and
10- to 14-fold in metastases relative to normal mucosae. One
recombinant, clone pLM59, represented an RNA showing a
4- to 6-fold increase in abundance in metastases relative to
primary tumours and normal mucosae (Tables III & IV). To
confirm that the observed differences in abundance of
Figure 4 Relative abundance of pNM32 RNA at different
stages in colorectal tumour progression. The relative abundance
of RNA homologous to recombinant plasmid pNM32 in tissue
specimens representing different stages of colorectal tumour
progression was determined by doubling dilution RNA dot-blot
hybridisation to 32P-labelled plasmid DNA. Total RNAs at a
concentration of 500igml-1 were diluted and applied to nitro-
cellulose as described in Materials and methods in a volume of
4,ud, the first dot in each series thus representing 2jug total RNA.
Other recombinants were screened in an identical manner against
an identical series of specimens on replica nitrocellulose filters.
Table III Relative abundances of five mRNAs in mucosae, polyps,
carcinomas and metastases
Recombinant clones
Tissue pNMJ9 pNM32 pNM41 pNM6J pLM59
Mucosa (4)' 104b 320 98 130 5
(32-128) (256-512) (8-128) (8-256) (4-8)
Polyp (3) 88 192 192 85 4
(8-128) (64-256) (64-256) (64-128) (4)
Carcinoma (4) 107 128 32 32 8
(64-128) (128) (32) (32) (8)
Metastases (2) 10 24 9 9 32
(4,16) (16,32) (1,16) (2,16) (32)
aNumber of individual samples. bMean values of reciprocals of
dilution end-points determined by total RNA doubling-dilution dot-
blot assay (see Figure 4), figures in brackets are the range of values.
Table IV Abundances of homologous RNAs in metastases relative
to mucosa and carcinoma
Recombinant clone
Abundance in
metastases pNMJ9 pNM32 pNM4J pNM6J pLM59
Relative to mucosa 0.1 0.08 0.09 0.07 6.4
Relative to carcinoma 0.1 0.19 0.28 0.28 4
sequences homologous to the cloned cDNAs were due to
differences in specific hybridisation and not to errors in the
estimates of the RNA content of the samples, the same dot
blots were stripped and reprobed with a cloned fragment of
human 18S ribosomal DNA (results not shown). RNA dot-
blot analysis also revealed considerable variation in the
abundance of homologous RNAs to the cloned sequences at
different stages of tumour progression (Table III). That these
differences were not attributable to degradation of the RNA
samples concerned was shown by hybridisation of Northern
blots to skeletal muscle actin (Shani et al., 1981) and I2-
microglobulin (Suggs et al., 1981) cDNA probes (results not
shown).
28S -
23S
lis -
16S -
0
0
0
'a
C)
1024
512
256
128
64
32
16
8
4
2
1
kb
p 2.1
-1.9
- 1.2
-0.8
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Relative abundance ofpLM59-homologous RNA
One of the aforementioned recombinants, pLM59, was of
particular interest since it appeared to represent a sequence
of greater abundance in liver metastases than in primary
tumours and normal tissue, and thus may have the potential
clinical application as a marker of metastatic disease. The
cDNA isolated by EcoRI/BamHI restriction enzyme digest,
and labelled by the 'random primed' method of Feinberg
and Vogerstein (1983), was used to screen a larger series of
RNA dot blots (Table V). The sequence was shown to
represent an mRNA of a maximum 4-fold increased
abundance in primary tumours, and a maximum 8-fold
increased abundance in liver metastases relative to normal
mucosae. There was some indication that the levels of
pLM59 homologous RNA were slightly elevated in those
primary tumours known to have metastasised relative to
those that had not, while the levels of homologous RNA in
the mucosae showed no differences correlated with the
presence or absence of metastatic disease.
Discussion
We previously screened cDNA libraries of about 1,000
recombinant clones from poly(A)+ RNAs representing
clinically metastasising and non-metastasising variants of
colorectal tumours (Kerr et al., 1983) and, although
quantitative RNA dot-blot hybridisation analysis identified
cDNA clones corresponding to sequences of greater
abundance in RNAs from tumours compared to normal
mucosae, no clones were found that consistently
distinguished between localised and disseminated disease.
The present study is based upon the random cloning of
cDNAs representing the steady-state levels of total poly(A)+
RNAs from normal mucosa and from a liver metastasis of a
colorectal carcinoma. The frequency of a single cloned
sequence in the cDNA library reflects the abundance of that
sequence in the original mRNA population, and is ultimately
determined by the turnover of the corresponding mRNA,
which in turn may depend on the parent tissue. The majority
of sequences comprising the abundant and moderately
abundant classes of mRNA from the 10,000-30,000 different
sequences in typical eukaryotic tissues may be expected to be
represented in a cDNA library of between 5,000 and 10,000
clones (Williams, 1981). Thus the libraries screened in this
study should have been large enough to contain most
abundant and moderately abundant sequences, although low
abundance mRNAs will not have been well represented or
detected. However, in a study of tissue-related differences in
mRNA populations, Hastie and Bishop (1976) concluded
that the most striking differences between tissues could be
found among the abundant sequences. Furthermore,
differences between normal and SV40-transformed human
fibroblast mRNA populations could be ascribed to a few
sequences of the high abundance mRNA classes (Williams et
al., 1977).
By screening two cDNA libraries we have identified a
number of cDNA clones homologous to RNAs of
significantly reduced or increased abundance in metastases
relative to neoplastic and normal colonic tissue. Screening
Table V Abundance of mRNA homologous to recombinant clone
pLM59 in colonic mucosae, primary colorectal tumours, and
metastases of colorectal tumours
Tissue Reciprocal ofdilution endpointa
Normal mucosae 32, 32, 8, 32, 32, 32*, 32*, 32*, 32*
Colorectal carcinoma 32, 64, 64, 64, 64, 128, 128*, 64*, 64*, 128*
Liver metastases 64, 128, 128, 32, 256
aValues from individual patients; *patients with known metastatic
disease.
those recombinants representing abundant RNAs common
to normal colonic tissue specimens identified sequences
expressed at different levels in primary and secondary
tumours. Similarly, screening those recombinants repre-
senting sequences common to liver metastases of colorectal
tumours identified sequences that represented RNAs
associated with colorectal neoplasia and metastasis.
Although histologically normal mucosa from tumour-bearing
patients may exhibit phenotypic changes associated with the
disease (Shamsuddin et al., 1981), these differences should
not have severely masked those specifically associated with
transformation or metastasis.
On the basis of colony and plasmid DNA dot
hybridisations the vast majority of cDNA clones in the two
libraries were found to correspond to abundant RNA
sequences shared by both normal and neoplastic colon; most
of these sequences were also present in the total poly(A)+
RNA of normal liver. Those sequences showing some
variation in abundance associated with tumour development
(representing only 0.4% of the total sequences examined)
were poorly represented in the poly(A)+ RNA of normal
liver, suggesting that the changes in abundance that occur do
so in sequences characteristic of the colon. Furthermore, the
clones we have identified suggest that the development of
metastatic tumour cell populations in colorectal tumours is
not solely due to the aberrant expression of one or two
genes, but rather to the subtle alteration of multiple genetic
loci. The results, however, do not allow any distinction to be
made between changes in gene expression that may be
associated with the prior existence of metastatic tumour cell
populations (Fidler et al., 1978) and those that may arise, for
example, as a result of selective pressures exerted by the host
microenvironment (Schirrmacher, 1980; Kerbel et al., 1984).
Changes in gene expression are implied in tumour
progression (Foulds, 1975) and the generation of clonal
diversity (Nowell, 1976) responsible for heterogeneity within
tumours for a number of phenotypic characteristics, which
may include metastatic capability (Fidler & Hart, 1982).
However, the precise nature of the genetic events associated
with tumour progression remain largely undetermined. A
number of cellular oncogenes have been identified as being
aberrantly expressed in colorectal cancer, including c-mj'c
(Rothberg et al., 1985; Stewart et al., 1986) c-myb (Alitalo et
al., 1984) c-Ha-ras and c-Ki-ras (Spandidos & Kerr, 1984).
Although decreased levels of p21ras were demonstrated in
metastases, regardless of site, compared to primary colon
tumours (Gallick et al., 1985) there appears to be no
correlation between the levels of ras-related cellular RNA
and clinical outcome with regard to the development of
metastatic disease (Kerr et al., 1986). Amplification of
c-myc may be correlated with tumour metastasis (Yokota
et al., 1986) and the transfection of cellular oncogenes
(Thorgeirsson et al., 1985) has shown them to be involved in
the acquisition of metastatic capability. Thus, although much
has been learned of the role of oncogenes in the process of
transformation, their role in metastasis is not clear, and it is
likely that other, as yet uncharacterised sequences (e.g.
Bernstein & Weinberg, 1985), may be related to the events
associated with the activation of oncogenes and other genes
during the metastatic process. In this regard pLM59 appears
to represent a hitherto unknown gene (no homologous
sequence was found in the Genbank sequence data bank)
whose expression is at least correlated with the process of
metastasis in colorectal cancer.
The significance of increases and decreases in abundance
of specific sequences of the order that we have reported, and
the effects of these changes in the complex pattern of events
associated with colorectal tumour development and
metastasis, are not yet known. The validity of the results
with respect to mRNA abundance also requires confirmation
in a larger series of specimens. The use of in situ
hybridisation to examine the localisation of mRNAs
homologous to the cloned sequences in both primary andMETASTASIS IN COLORECTAL CANCER 41
secondary tumour cell populations and the analysis of the
sequences involved may clarify this. These sequences may
also prove to be of considerable prognostic value in
predicting the metastatic capability of primary tumours at
the time of surgery.
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